Archives

by in
Entry Author Date Location
The Icos Impact: What to Expect Next Week 11/20/12 Seattle
The Icos Impact: A Few Photos From Memory Lane 11/07/12 Seattle
Omeros Passes 2nd Trial for Eye Drug, Preps for FDA Push 11/05/12 Seattle
Omeros Settles Wrongful Termination Suit With Former CFO for $3.9M 11/01/12 Seattle
Digging in the Closet for Halloween? Get Out Your Icos Mementos 10/30/12 Seattle
Join Cliff Stocks, Pat Gray, Mike Gallatin & More Nov. 27 for ‘The Icos Impact’ 09/20/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Omeros Pockets $28M in Stock Sale 06/28/12 Seattle
Accelerator Gets New Chief Scientist, David McElligott 03/28/12 Seattle
The Greater Seattle Brain Science Cluster 03/16/12 Seattle
Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb 03/13/12 Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News 04/07/11 Seattle
Omeros Fails in Pivotal Trials With Drug for Knee Surgery, Stock Crashes 03/31/11 Seattle
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News 03/24/11 Seattle
Omeros Combo Drug Passes Cataract Surgery Study 03/23/11 Seattle
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News 01/06/11 Seattle
Omeros Gets Drugs for Bleeding 01/05/11 Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News 12/16/10 Seattle
Life Sciences Discovery Fund Debunks Perceptions with Omeros Deal, Shows State Can Bankroll Companies 12/14/10 Seattle
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News 11/24/10 Seattle
Omeros Adds Discovery Technology 11/23/10 Seattle
Omeros Nabs $25M from Paul Allen and the State, Immune Design Strikes 1st Big Deal, & More Seattle-Area Life Sciences News 10/28/10 Seattle
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets 10/25/10 Seattle
Omeros Addiction Program Wins NIH Grant 10/14/10 Seattle
Omeros Lines Up $40M Financing 07/29/10 Seattle
Ironwood Climbs 3.6 Percent on IPO Debut Day, Shows Investor Interest—Albeit Tepid—in Biotech 02/03/10 Boston
Ironwood Pharma IPO Price Cut Could Be Only Half the Story 02/03/10 Boston
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry 02/01/10 Boston
M&A Liquidity Up, IPO Market Still Anemic: Fourth-Quarter Data on Venture Exits Is a Mixed Bag 01/04/10 National
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.